Skip to main content
Erschienen in: Journal of Urban Health 3/2006

01.05.2006

From Corrections to Communities as an HIV Priority

verfasst von: David Vlahov, PhD, Sara Putnam

Erschienen in: Journal of Urban Health | Ausgabe 3/2006

Einloggen, um Zugang zu erhalten

Excerpt

The health of inmates in correctional facilities has been a longstanding concern in the medical community1 and historically has centered on the health of populations entering correctional settings, which may affect the risk of infectious disease transmission inside these facilities.2,3 Recently, however, more attention has been devoted to public health consequences of inmates released to the community, where continuity of care represents a challenge for treatment and prevention, and there is an increasing appreciation of inmates being part of the public health in the community to which they are released.4,5 In 1983, the first case of AIDS was reported from a prison in the United States.6 Since that time, nearly 5% of the HIV/AIDS cases in the U.S. have been reported from correctional facilities, although the census for these facilities account for less than 1% of the population.6 This disproportionate representation of AIDS cases has garnered attention, and AIDS in the correctional setting over the past two decades provides an illustration of the changing and evolving perspectives on health in corrections facilities and also highlights areas where improvements in knowledge and intervention efforts can be made. …
Literatur
1.
Zurück zum Zitat Derro RA. Health problems in a city-county workhouse. Public Health Rep. 1978;93:379–385.PubMed Derro RA. Health problems in a city-county workhouse. Public Health Rep. 1978;93:379–385.PubMed
2.
Zurück zum Zitat Niveau G. Prevention of infectious disease transmission in correctional settings: a review. Public Health. 2006;120(1):33–41.PubMedCrossRef Niveau G. Prevention of infectious disease transmission in correctional settings: a review. Public Health. 2006;120(1):33–41.PubMedCrossRef
3.
Zurück zum Zitat Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS. 2005;19(Suppl 3):S41–S46.PubMedCrossRef Weinbaum CM, Sabin KM, Santibanez SS. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS. 2005;19(Suppl 3):S41–S46.PubMedCrossRef
4.
Zurück zum Zitat Springer SA, Altice FL. Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep. 2005;2:165–170.PubMedCrossRef Springer SA, Altice FL. Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep. 2005;2:165–170.PubMedCrossRef
5.
Zurück zum Zitat Freudenberg N. Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health. J Urban Health. 2001;78:214–235.PubMed Freudenberg N. Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health. J Urban Health. 2001;78:214–235.PubMed
6.
Zurück zum Zitat Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from U.S. correctional facilities, 1997. Am J Public Health. 2002;92(11):1789–1794.PubMed Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from U.S. correctional facilities, 1997. Am J Public Health. 2002;92(11):1789–1794.PubMed
7.
Zurück zum Zitat Decker MD, Vaughn WK, Brodie JS, et al. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis. 1984;150:450–459.PubMed Decker MD, Vaughn WK, Brodie JS, et al. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis. 1984;150:450–459.PubMed
8.
Zurück zum Zitat Anda RF, Perlman SB, D'Alessio DJ, Davis JP, Dodson VN. Hepatitis B in Wisconsin male prisoners: considerations for serologic screening and vaccination. Am J Public Health. 1985;75(10):1182–1185.PubMed Anda RF, Perlman SB, D'Alessio DJ, Davis JP, Dodson VN. Hepatitis B in Wisconsin male prisoners: considerations for serologic screening and vaccination. Am J Public Health. 1985;75(10):1182–1185.PubMed
9.
Zurück zum Zitat Hull HF, Lyons LH, Mann JM, Hadler SC, Steece R, Skeels MR. Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health. 1985;75(10):1213–1214.PubMed Hull HF, Lyons LH, Mann JM, Hadler SC, Steece R, Skeels MR. Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health. 1985;75(10):1213–1214.PubMed
10.
Zurück zum Zitat Miller N, Moses L, eds. Confronting AIDS. Washington, DC: National Academy Press, 1990. Miller N, Moses L, eds. Confronting AIDS. Washington, DC: National Academy Press, 1990.
11.
Zurück zum Zitat Kinsey AC, Pomeroy WR, Martin CE. Sexual behavior in the human male, 1948. Am J Public Health. 2003;93(6):894–898.PubMed Kinsey AC, Pomeroy WR, Martin CE. Sexual behavior in the human male, 1948. Am J Public Health. 2003;93(6):894–898.PubMed
12.
Zurück zum Zitat Vlahov D, Brewer TF, Munoz A, et al. Temporal trends of human immunodeficiency virus type-1 (HIV 1) infection among inmates entering a statewide prison system, 1985–1987. J Aquir Immune Defic Syndr. 1989;2:283–290. Vlahov D, Brewer TF, Munoz A, et al. Temporal trends of human immunodeficiency virus type-1 (HIV 1) infection among inmates entering a statewide prison system, 1985–1987. J Aquir Immune Defic Syndr. 1989;2:283–290.
13.
Zurück zum Zitat Des Jarlais DC, Friedman SR. HIV epidemiology and interventions among injecting drug users. Int J STD AIDS. 1996;7(Suppl 2):57–61.PubMedCrossRef Des Jarlais DC, Friedman SR. HIV epidemiology and interventions among injecting drug users. Int J STD AIDS. 1996;7(Suppl 2):57–61.PubMedCrossRef
14.
Zurück zum Zitat Vlahov D, Munoz A, Brewer F, Taylor E, Canner C, Polk BF. Seasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons: update. AIDS. 1990;4:345–350.PubMedCrossRef Vlahov D, Munoz A, Brewer F, Taylor E, Canner C, Polk BF. Seasonal and annual variation of antibody to HIV-1 among male inmates entering Maryland prisons: update. AIDS. 1990;4:345–350.PubMedCrossRef
15.
Zurück zum Zitat Behrendt C, Kendig N, Dambita C, Horman J, Lawlor J, Vlahov D. Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol. 1994;139:918–926.PubMed Behrendt C, Kendig N, Dambita C, Horman J, Lawlor J, Vlahov D. Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol. 1994;139:918–926.PubMed
16.
Zurück zum Zitat Kassira EN, Bauserman RL, Tomoyasu N, Cladeira E, Swetz A, Solomon L. HIV and AIDS surveillance among inmates in Maryland prisons. J Urban Health. 2001;78:256–263.PubMed Kassira EN, Bauserman RL, Tomoyasu N, Cladeira E, Swetz A, Solomon L. HIV and AIDS surveillance among inmates in Maryland prisons. J Urban Health. 2001;78:256–263.PubMed
17.
Zurück zum Zitat Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health. 2004;81:21–37. Solomon L, Flynn C, Muck K, Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health. 2004;81:21–37.
18.
Zurück zum Zitat Vlahov D, Brewer TF, Castro KG, Narkunas JP, Salive ME, Ullrich J, Munoz A. Prevalence of antibody to HIV-1 among entrants to U.S. correctional facilities. JAMA. 1991;265:1129–1132.PubMedCrossRef Vlahov D, Brewer TF, Castro KG, Narkunas JP, Salive ME, Ullrich J, Munoz A. Prevalence of antibody to HIV-1 among entrants to U.S. correctional facilities. JAMA. 1991;265:1129–1132.PubMedCrossRef
19.
Zurück zum Zitat Glass GE, Hausler WJ, Loeffelholz PL, Yesalis CE 3rd. Seroprevalence of HIV antibody among individuals entering the Iowa Prison System. Am J Public Health. 1988;78:447–919.PubMed Glass GE, Hausler WJ, Loeffelholz PL, Yesalis CE 3rd. Seroprevalence of HIV antibody among individuals entering the Iowa Prison System. Am J Public Health. 1988;78:447–919.PubMed
20.
Zurück zum Zitat Weisfuse IB, Greenberg BL, Back SD, Makki, et al. HIV-1 infection among New York City inmates. AIDS. 1991;5:1133–1138.PubMedCrossRef Weisfuse IB, Greenberg BL, Back SD, Makki, et al. HIV-1 infection among New York City inmates. AIDS. 1991;5:1133–1138.PubMedCrossRef
21.
Zurück zum Zitat Smith PF, Mikl J, Truman BI, et al. HIV infection among women entering the New York State correctional system. Am J Public Health. 1991;81(Suppl):35–40.PubMed Smith PF, Mikl J, Truman BI, et al. HIV infection among women entering the New York State correctional system. Am J Public Health. 1991;81(Suppl):35–40.PubMed
22.
Zurück zum Zitat Rich JD, Dickinson BP, Macalino G, et al. Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. J Acquir Immune Defic Syndr. 1999;22:161–166.PubMed Rich JD, Dickinson BP, Macalino G, et al. Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island. J Acquir Immune Defic Syndr. 1999;22:161–166.PubMed
23.
Zurück zum Zitat Altice FL, Mostashari F, Selwyn PA, et al. Predictors of HIV infection among newly sentenced male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:444–453.PubMed Altice FL, Mostashari F, Selwyn PA, et al. Predictors of HIV infection among newly sentenced male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:444–453.PubMed
24.
Zurück zum Zitat Wu ZH, Baillargeon J, Grady JJ, Black SA, Dunn K. HIV seroprevalence among newly incarcerated inmates in the Texas correctional system. Ann Epidemiol. 2001;11:342–346.PubMedCrossRef Wu ZH, Baillargeon J, Grady JJ, Black SA, Dunn K. HIV seroprevalence among newly incarcerated inmates in the Texas correctional system. Ann Epidemiol. 2001;11:342–346.PubMedCrossRef
25.
Zurück zum Zitat Hoxie NJ, Chen MH, Prieve A, Haase B, Pfister J, Vergeront JM. HIV seroprevalence among male prison inmates in the Wisconsin Correctional System. WMJ. 1998;97(5):28–31.PubMed Hoxie NJ, Chen MH, Prieve A, Haase B, Pfister J, Vergeront JM. HIV seroprevalence among male prison inmates in the Wisconsin Correctional System. WMJ. 1998;97(5):28–31.PubMed
26.
Zurück zum Zitat Takashima HT, Cruess DF, McDonald KR, Duggirala S, Gaydos JC. Tuberculosis and HIV infection in new inmates in Federal Bureau of Prisons facilities. Mil Med. 1996;161(5):265–267.PubMed Takashima HT, Cruess DF, McDonald KR, Duggirala S, Gaydos JC. Tuberculosis and HIV infection in new inmates in Federal Bureau of Prisons facilities. Mil Med. 1996;161(5):265–267.PubMed
27.
Zurück zum Zitat Ruiz JD, Molitor F, Plagenhoef JA. Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS. 2002;16:2236–2238.PubMedCrossRef Ruiz JD, Molitor F, Plagenhoef JA. Trends in hepatitis C and HIV infection among inmates entering prisons in California, 1994 versus 1999. AIDS. 2002;16:2236–2238.PubMedCrossRef
28.
Zurück zum Zitat Kim AA, McFarland W, Kellogg T, Katz MH. Sentinel surveillance for HIV infection and risk behavior among adolescents entering juvenile detention in San Francisco: 1990–1995. AIDS. 1999;20:1597–1598.CrossRef Kim AA, McFarland W, Kellogg T, Katz MH. Sentinel surveillance for HIV infection and risk behavior among adolescents entering juvenile detention in San Francisco: 1990–1995. AIDS. 1999;20:1597–1598.CrossRef
29.
Zurück zum Zitat Carpenter CL, Longshore D, Annon K, Annon JJ, Anglin MD. Prevalence of HIV-1 among recent arrestees in Los Angeles County, California: serial cross-sectional study, 1991–1995. J Acquir Immune Defic Syndr. 1999;21:172–177.PubMed Carpenter CL, Longshore D, Annon K, Annon JJ, Anglin MD. Prevalence of HIV-1 among recent arrestees in Los Angeles County, California: serial cross-sectional study, 1991–1995. J Acquir Immune Defic Syndr. 1999;21:172–177.PubMed
30.
Zurück zum Zitat Sabin KM, Frey RL Jr, Horsley R, Greby SM. Characteristics and trends of newly identified HIV infections among incarcerated populations: CDC HIV voluntary counseling, testing, and referral system, 1992–1998. J Urban Health. 2001;78:241–255.PubMed Sabin KM, Frey RL Jr, Horsley R, Greby SM. Characteristics and trends of newly identified HIV infections among incarcerated populations: CDC HIV voluntary counseling, testing, and referral system, 1992–1998. J Urban Health. 2001;78:241–255.PubMed
31.
Zurück zum Zitat Nacci PL, Kane TR. Sex and sexual aggression in federal prisons. Federal Prison System, U.S. Department of Justice. Prog Rep. 1982;1:7–12. Nacci PL, Kane TR. Sex and sexual aggression in federal prisons. Federal Prison System, U.S. Department of Justice. Prog Rep. 1982;1:7–12.
32.
Zurück zum Zitat Robertson JE. Rape among incarcerated men: sex, coercion and STDs. AIDS Patient Care STDS. 2003;17:423–430.PubMedCrossRef Robertson JE. Rape among incarcerated men: sex, coercion and STDs. AIDS Patient Care STDS. 2003;17:423–430.PubMedCrossRef
33.
Zurück zum Zitat Wohl AR, Johnson D, Jordan W, et al. High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr. 2000;24:386–392.PubMed Wohl AR, Johnson D, Jordan W, et al. High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr. 2000;24:386–392.PubMed
34.
Zurück zum Zitat Clarke JG, Stein MD, Hanna L, Sobota M, Rich JD. Active and former injection drug users report of HIV risk behaviors during periods of incarceration. Subst Abus. 2001 Dec;22(4):209–216.PubMedCrossRef Clarke JG, Stein MD, Hanna L, Sobota M, Rich JD. Active and former injection drug users report of HIV risk behaviors during periods of incarceration. Subst Abus. 2001 Dec;22(4):209–216.PubMedCrossRef
35.
Zurück zum Zitat Historical summary of sentencing and punishment in Florida: 1980 to 1999. Tallahassee, Florida: Department of Corrections, 1999. Historical summary of sentencing and punishment in Florida: 1980 to 1999. Tallahassee, Florida: Department of Corrections, 1999.
36.
Zurück zum Zitat Vlahov D, Polk BF. Intravenous drug use and human immunodeficiency virus infection in prison. AIDS Publ Policy J. 1988;3:42–46. Vlahov D, Polk BF. Intravenous drug use and human immunodeficiency virus infection in prison. AIDS Publ Policy J. 1988;3:42–46.
37.
Zurück zum Zitat Kelly PW, Redfield RR, Ward DL. Prevalence and incidence of HTLV-III infection in a prison. JAMA. 1986;256:2198–2199.CrossRef Kelly PW, Redfield RR, Ward DL. Prevalence and incidence of HTLV-III infection in a prison. JAMA. 1986;256:2198–2199.CrossRef
38.
Zurück zum Zitat Horsburgh CR Jr, Jarvis JQ, MacArthur T, et al. Seroconversion to human immunodeficiency virus infection in prison inmates. Am J Public Health. 1990;80:209–210.PubMed Horsburgh CR Jr, Jarvis JQ, MacArthur T, et al. Seroconversion to human immunodeficiency virus infection in prison inmates. Am J Public Health. 1990;80:209–210.PubMed
39.
Zurück zum Zitat Brewer TF, Vlahov D, Taylor E, et al. Transmission of HIV-1 within a statewide prison system. AIDS. 1988;2:363–367.PubMedCrossRef Brewer TF, Vlahov D, Taylor E, et al. Transmission of HIV-1 within a statewide prison system. AIDS. 1988;2:363–367.PubMedCrossRef
40.
Zurück zum Zitat Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94:1218–1223.PubMed Macalino GE, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94:1218–1223.PubMed
41.
Zurück zum Zitat Mutter RC, Grimes RM, Labrathe D. Evidence of intraprison spread of HIV infection. Arch Intern Med. 1994;154:793–795.PubMedCrossRef Mutter RC, Grimes RM, Labrathe D. Evidence of intraprison spread of HIV infection. Arch Intern Med. 1994;154:793–795.PubMedCrossRef
42.
Zurück zum Zitat Taylor A, Goldberg D, Emslie J, et al. Outbreak of HIV infection in a Scottish prison. BMJ. 1995;310(6975):289–292.PubMed Taylor A, Goldberg D, Emslie J, et al. Outbreak of HIV infection in a Scottish prison. BMJ. 1995;310(6975):289–292.PubMed
43.
Zurück zum Zitat Gore SM, Bird AG. HIV transmission in jail. BMJ. 307:147–148. Gore SM, Bird AG. HIV transmission in jail. BMJ. 307:147–148.
44.
Zurück zum Zitat Choopanya K, Des Jarlais DC, Vanichseni S, et al. Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr. 2002;29:86–94.PubMed Choopanya K, Des Jarlais DC, Vanichseni S, et al. Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr. 2002;29:86–94.PubMed
45.
Zurück zum Zitat Centers for Disease Control and Prevention. HIV/AIDS education and prevention programs for adults in prisons and jails and juveniles in confinement facilities—United States. JAMA. 1996;275:1306–1308.CrossRef Centers for Disease Control and Prevention. HIV/AIDS education and prevention programs for adults in prisons and jails and juveniles in confinement facilities—United States. JAMA. 1996;275:1306–1308.CrossRef
46.
Zurück zum Zitat Braithwaite RL, Arriola KR. Male prisoners and HIV prevention: a call for action ignored. Am J Public Health. 2003;93:759–763.PubMed Braithwaite RL, Arriola KR. Male prisoners and HIV prevention: a call for action ignored. Am J Public Health. 2003;93:759–763.PubMed
47.
Zurück zum Zitat Belenko S, Shedlin M, Chaple M. HIV risk behaviors, knowledge and prevention service experiences among African American and other offenders. J Health Care Poor Underserved. 2005;16(4 Suppl B):108–127.PubMedCrossRef Belenko S, Shedlin M, Chaple M. HIV risk behaviors, knowledge and prevention service experiences among African American and other offenders. J Health Care Poor Underserved. 2005;16(4 Suppl B):108–127.PubMedCrossRef
49.
Zurück zum Zitat Andrus JK, Fleming DW, Knox C, et al. HIV testing in prisoners: is mandatory testing mandatory? Am J Public Health. 1989;79:8400–8402. Andrus JK, Fleming DW, Knox C, et al. HIV testing in prisoners: is mandatory testing mandatory? Am J Public Health. 1989;79:8400–8402.
50.
Zurück zum Zitat Hoxie NJ, Vergeront JM, Frisby HR, Pfister JR, Golubjatnikov R, Davis JP. HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin. Am J Public Health. 1990;80:1129–11231.PubMedCrossRef Hoxie NJ, Vergeront JM, Frisby HR, Pfister JR, Golubjatnikov R, Davis JP. HIV seroprevalence and the acceptance of voluntary HIV testing among newly incarcerated male prison inmates in Wisconsin. Am J Public Health. 1990;80:1129–11231.PubMedCrossRef
51.
Zurück zum Zitat Weinbaum C, Lyerla R, Margolis HS, Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Recomm Rep. 2003;52(RR-1):1–36.PubMed Weinbaum C, Lyerla R, Margolis HS, Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Recomm Rep. 2003;52(RR-1):1–36.PubMed
52.
Zurück zum Zitat Berzin T, Allen S, Taylor L, Rich J, Feller E. Management of hepatitis C in Rhode Island: opportunities for improvement within and beyond the department of corrections. Med Health RI. 2002;85:341–344. Berzin T, Allen S, Taylor L, Rich J, Feller E. Management of hepatitis C in Rhode Island: opportunities for improvement within and beyond the department of corrections. Med Health RI. 2002;85:341–344.
53.
Zurück zum Zitat Lo CC, Stephens RC. Drugs and prisoners: treatment needs on entering prison. Am J Drug Alcohol Abuse. May 2000;26(2):229–245.PubMedCrossRef Lo CC, Stephens RC. Drugs and prisoners: treatment needs on entering prison. Am J Drug Alcohol Abuse. May 2000;26(2):229–245.PubMedCrossRef
54.
Zurück zum Zitat Pelissier B, Wallace S, O'Neil JA, et al. Federal prison residential drug treatment reduces substance sue and arrests after release. Am J Drug Alcohol Abuse. 2001;27:315–337.PubMedCrossRef Pelissier B, Wallace S, O'Neil JA, et al. Federal prison residential drug treatment reduces substance sue and arrests after release. Am J Drug Alcohol Abuse. 2001;27:315–337.PubMedCrossRef
55.
Zurück zum Zitat Phillips JA, Nixon SJ, Phillips M, Pfefferbaum B, Briody R. A comparison of substance use between female inmates and female substance misusers in treatment. Alcohol Alcohol. 2000;35:60–65.PubMed Phillips JA, Nixon SJ, Phillips M, Pfefferbaum B, Briody R. A comparison of substance use between female inmates and female substance misusers in treatment. Alcohol Alcohol. 2000;35:60–65.PubMed
56.
Zurück zum Zitat Whitling NJ. New policy on methadone maintenance treatment in prisons established in Alberta. Can HIV AIDS Policy Law Rev. 2003;8:45–47.PubMed Whitling NJ. New policy on methadone maintenance treatment in prisons established in Alberta. Can HIV AIDS Policy Law Rev. 2003;8:45–47.PubMed
57.
Zurück zum Zitat Rich JD, Boutwell AE, Sheild DC, et al. J Urban Health. 2005;82(3):411–419.PubMed Rich JD, Boutwell AE, Sheild DC, et al. J Urban Health. 2005;82(3):411–419.PubMed
58.
Zurück zum Zitat May JP, Williams EL Jr. Acceptability of condom availability in a U.S. jail. AIDS Educ Prev. 2002;14(5 Suppl B):85–91.PubMedCrossRef May JP, Williams EL Jr. Acceptability of condom availability in a U.S. jail. AIDS Educ Prev. 2002;14(5 Suppl B):85–91.PubMedCrossRef
59.
Zurück zum Zitat Needle exchange ends HIV transmission in Swiss jail. AIDS Policy Law. 1996;11(13):9. Needle exchange ends HIV transmission in Swiss jail. AIDS Policy Law. 1996;11(13):9.
60.
Zurück zum Zitat Vlahov D, Anthony JC, Munoz A, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug use: description of methods and characteristics of participants. NIDA Res Monogr. 1991;109:75–100.PubMed Vlahov D, Anthony JC, Munoz A, et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug use: description of methods and characteristics of participants. NIDA Res Monogr. 1991;109:75–100.PubMed
61.
Zurück zum Zitat Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988–1988. Am J Epidemiol. 2002;156:641–653.PubMedCrossRef Nelson KE, Galai N, Safaeian M, Strathdee SA, Celentano DD, Vlahov D. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988–1988. Am J Epidemiol. 2002;156:641–653.PubMedCrossRef
62.
Zurück zum Zitat Alcabes P, Vlahov D, Anthony JC. Characteristics of intravenous drug users by history of arrest and treatment for drug use. J Nerv Ment Dis. 1992;180:48–54.PubMedCrossRef Alcabes P, Vlahov D, Anthony JC. Characteristics of intravenous drug users by history of arrest and treatment for drug use. J Nerv Ment Dis. 1992;180:48–54.PubMedCrossRef
63.
Zurück zum Zitat Verger P, Rotily M, Prudhomme J, Bird S. High mortality rates among inmates during the year following their discharge from a French prison. J Forensic Sci. 2003;48:614–616.PubMed Verger P, Rotily M, Prudhomme J, Bird S. High mortality rates among inmates during the year following their discharge from a French prison. J Forensic Sci. 2003;48:614–616.PubMed
64.
Zurück zum Zitat Bird SM, Hutchinson SJ. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996–99. Addiction. 2003;98:185–190.PubMedCrossRef Bird SM, Hutchinson SJ. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996–99. Addiction. 2003;98:185–190.PubMedCrossRef
65.
Zurück zum Zitat Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ. 1998;316(7129):426–428.PubMed Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ. 1998;316(7129):426–428.PubMed
66.
Zurück zum Zitat Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health. 2001;91:1842–1846.PubMedCrossRef Seal KH, Kral AH, Gee L, et al. Predictors and prevention of nonfatal overdose among street recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am J Public Health. 2001;91:1842–1846.PubMedCrossRef
67.
Zurück zum Zitat Murray KF, Richardson LP, Morishima C, Owens JW, Gretch DR. Prevalence of hepatitis C virus infection and risk factors in an incarcerated juvenile population: a pilot study. Pediatrics. 2003;111:153–157.PubMedCrossRef Murray KF, Richardson LP, Morishima C, Owens JW, Gretch DR. Prevalence of hepatitis C virus infection and risk factors in an incarcerated juvenile population: a pilot study. Pediatrics. 2003;111:153–157.PubMedCrossRef
68.
Zurück zum Zitat Baillargeon J, Wu H, Kelley MJ, Grady J, Linthicum L, Dunn K. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health. 2003;117:43–48.PubMedCrossRef Baillargeon J, Wu H, Kelley MJ, Grady J, Linthicum L, Dunn K. Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system. Public Health. 2003;117:43–48.PubMedCrossRef
69.
Zurück zum Zitat van Olphen J, Freudenberg N, Fortin P, Galea S. Community reentry: perceptions of people with substance use problems returning home from New York City jails. J Urban Health. 2006;83(3). van Olphen J, Freudenberg N, Fortin P, Galea S. Community reentry: perceptions of people with substance use problems returning home from New York City jails. J Urban Health. 2006;83(3).
70.
Zurück zum Zitat McLean RL, Robarge J, Sherman SG. Release from jail: moment of crisis or window of opportunity for female detainees? J Urban Health. 2006;83(3). McLean RL, Robarge J, Sherman SG. Release from jail: moment of crisis or window of opportunity for female detainees? J Urban Health. 2006;83(3).
71.
Zurück zum Zitat Richie BE, Freudenberg N, Page J. Reintegrating women leaving jail into urban communities: a description of a model program. J Urban Health. 2001;78(2):290–303.PubMed Richie BE, Freudenberg N, Page J. Reintegrating women leaving jail into urban communities: a description of a model program. J Urban Health. 2001;78(2):290–303.PubMed
72.
Zurück zum Zitat Rich JD, Holmes L, Salas C, et al. Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health. 2001;78(2):279–289.PubMed Rich JD, Holmes L, Salas C, et al. Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health. 2001;78(2):279–289.PubMed
73.
Zurück zum Zitat Ehrmann T. Community-based organizations and HIV prevention for incarcerated populations: three HIV prevention program models. AIDS Educ Prev. 2002;14(5 Suppl B):75–84.PubMedCrossRef Ehrmann T. Community-based organizations and HIV prevention for incarcerated populations: three HIV prevention program models. AIDS Educ Prev. 2002;14(5 Suppl B):75–84.PubMedCrossRef
74.
Zurück zum Zitat Inciardi JA. HIV risk reduction and service delivery strategies in criminal justice settings. J Subst Abuse Treat. 1996;13:421–428.PubMedCrossRef Inciardi JA. HIV risk reduction and service delivery strategies in criminal justice settings. J Subst Abuse Treat. 1996;13:421–428.PubMedCrossRef
75.
Zurück zum Zitat Bauserman RL, Richardson D, Ward M, et al. HIV prevention with jail and prison inmates: Maryland's Prevention Case Management program. AIDS Educ Prev. 2003;15:465–480.PubMedCrossRef Bauserman RL, Richardson D, Ward M, et al. HIV prevention with jail and prison inmates: Maryland's Prevention Case Management program. AIDS Educ Prev. 2003;15:465–480.PubMedCrossRef
76.
Zurück zum Zitat Needels K, James-Burdumy S, Burghardt J. Community case management for former jail inmates: its impacts on rearrest, drug use and HIV risk. J Urban Health. 2005;82(3):420–433.PubMed Needels K, James-Burdumy S, Burghardt J. Community case management for former jail inmates: its impacts on rearrest, drug use and HIV risk. J Urban Health. 2005;82(3):420–433.PubMed
77.
Zurück zum Zitat Braithwaite R, Stephens TT, Treadwell H, Braithwate K, Conerly R. J Health Care Poor Underserved. 2005;16(4 Suppl B) :130–139.PubMedCrossRef Braithwaite R, Stephens TT, Treadwell H, Braithwate K, Conerly R. J Health Care Poor Underserved. 2005;16(4 Suppl B) :130–139.PubMedCrossRef
78.
Zurück zum Zitat Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120:84–88.PubMed Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep. 2005;120:84–88.PubMed
Metadaten
Titel
From Corrections to Communities as an HIV Priority
verfasst von
David Vlahov, PhD
Sara Putnam
Publikationsdatum
01.05.2006
Verlag
Springer US
Erschienen in
Journal of Urban Health / Ausgabe 3/2006
Print ISSN: 1099-3460
Elektronische ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-006-9041-x

Weitere Artikel der Ausgabe 3/2006

Journal of Urban Health 3/2006 Zur Ausgabe